Search published articles


Showing 2 results for Mohammadian
Skin cancer incidence rate and trend in 2004-2008 in Tehran province
Maryam Mirzaei, Saeid Razi, Mahshid Ghoncheh, Abdollah Mohammadian Hafshejani, Hamid Salehiniya,
Volume 5, Issue 4 (Volume 5, Number 4 2015)
Abstract

Background and Aim: Skin cancer is the most common cancer in the world, which is associated with mortality, mortality and health care costs. Planning prevention and control of this cancer, information about its incidence rates and incidence trends is necessary. The present study aimed to determine the incidence rates and trends of skin cancer in Tehran.

Methods: In this cross-sectional study, necessary data were extracted from the Cancer Registry, Ministry of Health and Medical Education between 2003 and 2008. Age - and sex -standardized incidence rates were calculated and the incidence rate trends were determined.

Results: Between 2003 and 2008, 7429 skin cancer cases were recorded, of which 4807 were men and 2622 were women. Skin cancer incidence had an increasing trend in Tehran and its incidence rate has increased from 8.99 in women and 11.52 in men in 2003 to 18.03 in women and 28.16 in men in 2008, respectively. In addition, incidence of skin cancer was increased with aging in both men and women. The incidence rate was higher in men than women.

Conclusion: Skin cancer incidence in Tehran is increasing, which could be due to population aging, environmental risk factors, and changes in life style. More comprehensive research is suggested to investigate the risk factors for this cancer in Tehran.


Cutaneous leishmaniasis in Iran: Demographic description and therapeutic outcomes
Mohammad Saatchi, Hamid Salehinia, Salman Khazaei, Mahdi Mohammadian, Abdollah Mohammadian-Hafshejani,
Volume 6, Issue 2 (Volume 6, Number 2 2015)
Abstract
Background and Aim: The aim of this study was to investigate various aspects of the treatment in patients with cutaneous leishmaniasis in Iran in the first half of 2014. Methods: This cross sectional study was conducted on the existing data of 3684 patients with cutaneous leishmaniasis, whom were registered at the Disease Management Center of the Iranian Ministry of Health in the first half of 2014. Version 11 of Stata was used for statistical analysis and the level of significance was considered equals to 0.05. Results: Of 3684 patients entered into the study (%55.1) were male and the mean age of the patients was 27±18 years. More than 34% of patients were treated with intralesional injections of meglumine antimoniate (MA) and 25% of patients recieved systemic MA injections. There were statistically significant correlations between the size and number of the lesions and the chosen treatment regimen (P<0.001). Thirty-five percent of patients treated with systemic MA between 7 to 10 days and 43.3% of patients recieved intralesional MA injections for 5 to 8 weeks. Conclusion: More than %99 of patients fully recovered without complication or treatment failure. It seems that Iranian patients suffered milder CL in comparison with some other coutries.
Page 1 from 1     

© 2025 , Tehran University of Medical Sciences, CC BY-NC 4.0

Designed & Developed by : Yektaweb